Nonpredictive value of fibrosis in dilated cardiomyopathy treated with metoprolol

Cardiovascular Pathology

Volumn 5, Issue 1, 1996, Pages 21-28

  Sinagra, Gianfranco ^a   Rakar, Serena ^a   Zecchin, Massimo ^a   Bussani, Rossana ^a   Silvestri, Furio ^a   Bassan, Fabio ^a   Gregori, Dario ^b   Perkan, Andrea ^a   Di Lenarda, Andrea ^a   Secoli, Gabriele ^a   Lardieri, Gerardina ^a   Camerini, Fulvio ^a  

^a MAGGIORE HOSPITAL   (Italy)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ADULT; ADVERSE DRUG REACTION; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030059607     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/1054-8807(95)00056-9     Document Type: Article

References (41)

1. Roberts WC. Defining idiopathic dilated cardiomyopathy: a courtroom discussion. Am J Cardiol 1989;63:893-896.
2. Codd MB, Sugrue DD, Gersh BJ, Melton LJ: Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation 1989; 80:564-572.
3. Lilienfeld DE, Sprafka, JM, Pham DL, Baxter J. Morbidity from congestive and hypertrophic cardiomyopathy in the Minneapolis-St. Paul Metropolitan Area: 1979-1984. Cardiology 1992;80:71-76.
4. Yonesaka S, Becker AE. Dilated cardiomyopathy: diagnostic accuracy of endomyocardial biopsy. Br Heart J 1987;58:156-161.
5. Davies MJ. The cardiomyopathies: a review of terminology, pathology, and pathogenesis. Histopathology 1984;8:363-393.
6. Camerini F, Salvi A, Sinagra G. Endomyocardial biopsy in dilated cardiomyopathy and myocarditis: which role? Int J Cardiol 1991;31:1-8.
7. Olsen EGJ. Endomyocardial biopsy. Br Heart J 1978;40:95-98.
8. Ferrans, UJ, Roberts WC. Myocardial biopsy: a useful diagnostic procedure or only a research tool? Am J Cardiol 1978;41:965-967.
9. Olsen EGJ. Special investigation of COCM: endomyocardial biopsies (morphologic analysis). Postgrad Med J 1978;54:486-490.
10. Mall G, Schwarz F, Derks H. Clinicopathologic correlations in congestive cardiomyopathy - a study on endomyocardial biopsies. Virchows Arch (Pathol Anat) 1982;397:67-82.
11. Tazelaar HD, Billingham M. Leukocytic infiltrates in idiopathic dilated cardiomyopathy. A source of confusion with active myocarditis. Am J Surg Pathol 1986;10:405-412.
12. Unverferth DV, Baker PB, Swift SE, et al. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol 1986;57:816-820.
13. Figulla HR, Rahlf G, Nieger M, Luig H, Kreuzer H. Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation 1985;71:1095-1104.
14. Valantine HA, Billingham ME, Heilbrunn SM, et al. Response to β-blockers in dilated cardiomyopathy predicted by myocardial biopsy. Circulation 1986;72:1174.
15. Yamada Y, Fukunami M, Ohmuri M, et al. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term β-blocker therapy? A histologic viewpoint. J Am Coll Cardiol 1992;21:628-633.
16. Waagstein F, Hjalmarson Å, Varnauskas E, Wallentin I. Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-1036.
17. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term β-blockade in congestive cardiomyopathy. Br Heart J 1980;44:117-133.
18. Engelmeier RS, O'Connel JB, Walsh R, Rad N, Scanlon PF, Gunnar RM. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation 1985;72:536-546.
19. Waagstein F, Caidahl K, Wallentin I, Bergh CH, Hjalmarson A. Long-term β-blockade in congestive cardiomyopathy: effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 1989;80:551-563.
20. Anderson JL, Gilbert EM, O'Connel JB, et al. Long-term (2 year) beneficial effects of β-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1991; 17:1373-1381.
21. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Results of the metoprolol in dilated cardiomyopathy (MDC) trial. A randomized, double-blind, placebo-controlled multicenter study. Lancet 1993;342:1441-1446.
22. Sinagra G, Perkan A, Di Lenarda A, et al. I Betabloccanti nella terapia della cardiomiopatia dilatativa: revisione delle letterature ed esperienza clinica su 67 pazienti. G Ital Cardiol 1992;22:969-989.
23. Eichhorn EI. The paradox of β-adrenergic blockade for the management of congestive heart failure. Am J Med 1992;92:527-538.
24. Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Br Heart J 1980;44:672-673.
25. Baandrup U, Olsen EGJ. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I: Morphologic and morphometric aspects. Br Heart J 1981;45:475-486.
26. Hauck AJ, Edwards WD. Histopathologic examination tissues obtained by endomyocardial biopsy. In: Fowles RE, eds. Cardiac Biopsy. New York: Futura, 1992:98-100.
27. Anderson KR, Sutton MGS, Lie JT. Histopathologic types of cardiac fibrosis in myocardial disease. J Pathol 1979;128:79-85.
28. Hosmer DV, Lemeshow S. Applied Logistic Regression. New York: John Wiley and Sons, 1989:108.
29. Schwarz F, Mall G, Zebe H, et al. Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation 1984;70:923-928.
30. Nakayama Y, Shimuzi G, Hirota Y, et al. Functional and hystopathologic correlation in patients with dilated cardiomyopathy: an integrated evaluation by multivariate analysis. J Am Coll Cardiol 1987;10:186-192.
31. Baandrup U, Florio RA, Rehan M, Richardson PJ, Olsen GJ. Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. II: Comparison of histology and clinical/hemodynamic information. Br Heart J 1981;45:487-493.
32. Unverferth DV, Magorien RD, Kolibash AJ, et al. Biochemical and histologic correlates of ventricular end-diastolic pressure. Int J Cardiol 1981;1:133-142.
33. Unverferth DV, Magorien RD, Moeschberger ML, Baker P, Fetters JK, Leier CV. Factors influencing the 1-year mortality of dilated cardiomyopathy. Am J Cardiol 1984;54:147-152.
34. Popma JJ, Cigarroa RG, Buja LM, Hillis LD. Diagnostic and prognostic utility of right-sided catheterization and endomyocardial biopsy in idiopathic dilated cardiomyopathy. Am J Cardiol 1989;63:955-958.
35. Anderson JL, Lutz JR, Gilbert EM, et al. A randomized trial of low-dose β-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 1985;55:471-475.
36. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy by β-receptor blockade. Lancet 1979;1:1374-1376.
37. Meckel CR, Wilson JE, Sears TD, Rogers JG, Goaley TJ, McManus BM. Myocardial fibrosis in endomyocardial biopsy specimens: do different bioptomes affect estimations? Am J Cardiovasc Pathol 1989;2:309-313.
38. Hess OM, Schneider J, Koch R, Bamert C, Grimm J, Krayenbuehl HP. Diastolic function and myocardial structure in patients with myocardial hypertrophy. Special reference to normalized viscoelastic data. Circulation 1981;63:360-371.
39. Kunkel B, Lapp H, Kober G, Kaltenbach M. Light microscopic evaluation of myocardial biopsies. In: Kaltenbach, Loogen, Olsen, eds. Berlin-Heidelberg/New York; Springer, 1978:63-70.
40. Baandrup U, Florio RA, Olsen EG. Do endomyocardial biopsies represent the morphology of the rest of the myocardium? A quantitative light microscopic study of single versus multiple biopsies with the King's bioptome. Eur Heart J 1982;3:171-178.
41. Schwarz F, Mall G, Zebe H, et al. Quantitative morphologic findings of the myocardium in idiopathic dilated cardiomyopathy. Am J Cardiol 1983;51:501-506.